Login
← Go Back
Divi's Laboratories
DIVISLAB · Pharma > Pharmaceuticals & Drugs · Chairman: Ramesh BV Nimmagadda · MD: Murali K Divi · Listing date: March 12, 2003 · Employees: 16818 · Hyderabad · http://www.divislabs.com
Stock Price vs Company Growth
1d
0.4%
1w
3.7%
1m
7.8%
3m
5.9%
6m
7.6%
1y
59.7%
5y
22.1%
10y
22.3%
all
23.3%
Created with Highcharts 8.2.2SalesProfitPriceDividendQtr SalesOperating CashflowDec10Jun14Dec17Jun21Latest
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 6,179 0.4%
4,942
6,307
Company Overview
Sales
9,078 Cr
Growth: 11.4%
Profit after Tax
2,067 Cr
Growth: 12.6%
Large Cap
1,64,037 Cr
P/E: 79.3x
Industry P/E: 32.3x
Created with Highcharts 8.2.2HistoricalGrowthValuationAttractivenessProfitabilityIndustryOutlookPriceStability10
Fundamentals
Sales (Cr) ₹ 9,078
Growth 11.4%
EBITDA 31.0%
P/S 18.1x
Dividend 0.6%
P/E 79.3x
Book Value ₹ 569
PEG Ratio 7.0x
ROE 14.5%
P/B 10.9x
Shareholding Pattern
Institutions
Sbi Mutual Fund
4.49 %
Qualified Institutional Buyer
3.57 %
Axis Mutual Fund Trustee Ltd
3.37 %
Government Pension Fund Global
1.29 %
Life Insurance Corporation Of India
1.15 %
Created with Highcharts 8.2.2Dec19Mar20Jun20Sep20Dec20Mar21Sep21Mar22Sep22Mar24Sep24
Promoters
Nilima Prasad Divi
20.34 %
Divi Satchandra Kiran
20.34 %
Divi Swarna Latha
5.27 %
Divi'S Biotech Private Limited
3.01 %
Murali Krishna Prasad Divi
2.85 %
Created with Highcharts 8.2.2Dec19Mar20Jun20Sep20Dec20Mar21Sep21Mar22Sep22Mar24Sep24
Others
Created with Highcharts 8.2.2Dec19Mar20Jun20Sep20Dec20Mar21Sep21Mar22Sep22Mar24Sep24
Increase    Decrease    No change
Company Profile Detailed
The Company manufactures Generic APIs, Nutraceutical Ingredients and offers Custom Synthesis of APIs to Big Pharma providing a competitive advantage over the entire life cycle of the products.
Belongs to (47 Indices) view more
Investors (131)
credit.s...
divi.mad...
valiant....
Followers (42)
deepak
jayapras...
nitin2